Popular Articles

Health Canada Is Warning Canadians Not To Use Clean Testing HIV Home Test Kit, Or Any Home HIV Test Kit
Health Canada is advising Canadians not to use Clean Testing HIV Home Test Kit, or any HIV home test kits, as these are unlicensed medical devices and may provide false test results.

Obama Says Lawmakers Should Not Become Sidetracked By Abortion Debate In Health Reform
In an interview with CBS" "Evening News" on Tuesday, President Obama said that lawmakers should "not get distracted by the abortion debate" as they weigh health reform legislation. When asked by "Evening News" anchor Katie Couric if he would "favor a government option that would cover abortions," Obama replied that what he thinks is "important, at this stage, is not trying to micro-manage what benefits are covered." He added that his "main focus is making sure that people have the options of high-quality care at the lowest possible price." Obama also said, "As you know, I"m pro-choice. But I think we also have the tradition of, in this town, historically, of not financing abortions as part of government-funded health care." He continued that "[r]ather than wade into that issue at this point, I think it"s appropriate for us to figure out how to just deliver on the cost savings, and not get distracted by the abortion debate at this station" (Couric, "Evening News," CBS, 7/21).
News of the day
Genetic Test Reduces Need For Second Surgery In Breast Cancer Treatment
A new rapid test can confirm quickly and accurately that breast cancer has most likely not spread into adjacent lymph nodes, offering reassurance to patients and reducing the need for a second operation.
Endocrinology

IntraOp Announces Two New Mobetron Orders In China

IntraOp Medical Corporation (OTCBB: IOPM), a provider of Intra-Operative Electron-beam Radiation Therapy (IOERT) solutions for the treatment and eradication of cancer, announced today two new orders for its Mobetron system from its Chinese distribution partner, Hui Long New Technology Co. LTD. IntraOp"s Mobetron is a mobile technology that delivers IOERT to a tumor site during cancer surgery. The Mobetron enables radiation and surgical oncologists to pinpoint the optimal site for radiation and to deliver an effective dose during the procedure. Since the Mobetron is a mobile, self-shielded device, doctors are able to move the Mobetron among operating rooms (ORs) to treat a greater number of patients more effectively, efficiently and cost-effectively than with a conventional linear accelerator. This order marks the fifth and sixth Mobetrons sold in China. In the twelve months since installing and utilizing the first device, oncologists in China have had notable success with IOERT, inspiring other centers to follow suit. Earlier this year, IntraOp sold and shipped Mobetrons to two Shanghai medical facilities, where they are currently being installed. This most recent order of two Mobetrons is for hospitals that should be ready for installation early next year. The order reflects Hui Long"s optimism about the near-term opportunities for Mobetron sales in China. Peter Yu, IntraOp"s Director of Far East Operations, noted, "With the very high patient loads our oncologists experience here in China, IOERT is often the only way to ensure that some patients are getting the radiation therapy treatment they need in a reasonable amount of time. With this order, we will be able to satisfy our customers" growing demand for a device that will enable them to deliver IOERT in the OR." IntraOp CEO John Powers added, "This order represents our fifth and sixth Mobetron sale in China in just 18 months. This adoption rate demonstrates China"s willingness to leap frog old technologies, while quickly adopting and standardizing on new technologies proven to provide superior outcomes. We are incredibly optimistic about this adoption rate and the Mobetron"s potential to benefit cancer patients." IntraOp Medical Corporation


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):